Apr 10, 2026 06:49AM
Apr 8, 2026 07:02AM
Apr 2, 2026 06:43AM
Apr 1, 2026 07:03AM
Apr 1, 2026 07:01AM
Mar 27, 2026 08:16AM
Mar 17, 2026 07:57AM Rodman & Renshaw Starts BioXcel Therapeutics (BTAI) at Buy, PT $17
Feb 12, 2026 07:01AM
Jan 20, 2026 07:01AM
Oct 17, 2025 06:48AM
Oct 14, 2025 07:03AM
Sep 22, 2025 06:47AM
Sep 11, 2025 10:34AM
Aug 27, 2025 06:55AM BioXcel Therapeutics (BTAI) Halted, News Pending
Aug 18, 2025 07:00AM
Aug 18, 2025 06:48AM
Aug 15, 2025 09:36AM
Aug 12, 2025 08:21AM
Aug 6, 2025 07:01AM
Aug 4, 2025 06:39AM
Jul 28, 2025 05:52AM BioXcel Therapeutics (BTAI) PT Lowered to $2 at Mizuho
Jul 22, 2025 06:41AM
Jul 21, 2025 07:01AM
Jul 3, 2025 06:50AM
Jul 1, 2025 07:02AM
Jun 23, 2025 06:39AM
May 27, 2025 08:01AM
May 12, 2025 07:01AM BioXcel Therapeutics (BTAI) Misses Q1 EPS by 129c
Mar 11, 2025 07:01AM
Mar 7, 2025 07:00AM
Mar 3, 2025 03:36PM
Mar 3, 2025 01:18PM
Mar 3, 2025 07:00AM
Feb 28, 2025 07:01AM
Feb 6, 2025 07:01AM BioXcel Therapeutics (BTAI) Announces 1:16 Reverse Share Split
Feb 5, 2025 07:00AM
Jan 30, 2025 06:40AM
Jan 7, 2025 07:18AM
Jan 6, 2025 06:58AM
Nov 22, 2024 08:18AM
Nov 21, 2024 04:48PM
Nov 19, 2024 07:20AM Mizuho Reiterates Neutral Rating on BioXcel Therapeutics (BTAI)
Nov 14, 2024 07:01AM
Nov 12, 2024 07:03AM
Oct 21, 2024 06:55AM
Oct 15, 2024 07:01AM
Sep 23, 2024 07:04AM
Sep 19, 2024 07:02AM
Sep 9, 2024 06:37AM Mizuho Reiterates Neutral Rating on BioXcel Therapeutics (BTAI)
Sep 6, 2024 06:57AM

396,800 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All